Leadership Overview
Bioventus has 5 executives leading key functions including strategy, operations, technology, finance, and human resources.
Driven by innovation, Bioventus is dedicated to bringing clinically effective, cost-efficient, minimally invasive medical treatments to market that engage and enhance the body's natural healing processes, impacting global healthcare.
Driven by innovation, Bioventus is dedicated to bringing clinically effective, cost-efficient, minimally invasive medical treatments to market that engage and enhance the body's natural healing processes, impacting global healthcare.
Leadership Roles at Bioventus
Anthony Bihl - Chief Executive Officer
Anthony Bihl, the Chief Executive Officer at Bioventus, directs the company's overarching strategy and operational execution. Bihl guides Bioventus in its mission to deliver innovative solutions for active healing, focusing on clinically effective and cost-efficient medical treatments. This leadership involves steering product development, acquisition strategies, and distribution agreements to meet the growing global demand for minimally invasive procedures. By ensuring alignment with the company's core values, Anthony Bihl drives the organization's commitment to enhancing the body's natural healing capabilities. The Chief Executive Officer's purview encompasses all facets of the business, ensuring sustainable growth and market leadership in the active healing sector. Bihl's strategic vision shapes the company's direction, fostering an environment of continuous improvement and patient-centric innovation across all global operations.
Michael McManus - President and Chief Executive Officer of Misonix Inc.
Michael McManus, the President and Chief Executive Officer of Misonix Inc. at Bioventus, spearheads the strategic direction and operational management of the Misonix division. McManus focuses on integrating Misonix's advanced technologies to complement Bioventus's active healing portfolio, driving innovation in minimally invasive medical treatments. This leadership role involves overseeing the development and market introduction of products that enhance the body's natural healing processes, ensuring clinical efficacy and cost-efficiency. Michael McManus directs efforts to expand market reach and solidify Bioventus's position as a global leader in active healing solutions. The President and Chief Executive Officer of Misonix Inc. ensures operational synergy between Misonix and the broader Bioventus organization, fostering a culture of technological advancement and commercial success. McManus's leadership is critical in realizing the full potential of Misonix's contributions to Bioventus's mission.
Mark Singleton - Senior VP & Chief Financial Officer
Mark Singleton, the Senior VP & Chief Financial Officer at Bioventus, directs the company's financial strategy, resource allocation, and fiscal operations. Singleton oversees all aspects of financial planning, accounting, and investor relations, ensuring the fiscal health and sustainable growth of Bioventus. This leadership role is crucial in supporting the company's mission to deliver clinically effective, cost-efficient medical treatments by managing capital effectively and identifying strategic investment opportunities. Mark Singleton's financial acumen guides the company's product development, acquisition, and distribution efforts, ensuring resources are aligned with market needs and innovation goals. The Senior VP & Chief Financial Officer plays a key part in evaluating business performance and driving operational efficiencies across the organization. Singleton's stewardship of Bioventus's finances is integral to its ability to enhance the body's natural healing processes globally.
Keith McBride - Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies
Keith McBride, the Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies at Bioventus, architects the company's technological roadmap and oversees critical research and development initiatives. McBride directs the innovation pipeline for pain and restorative therapies, ensuring Bioventus brings cutting-edge, minimally invasive solutions to market. This leadership involves identifying and developing new product opportunities that leverage and enhance the body's natural healing mechanisms, aligning with the company's core mission. Keith McBride's focus on R&D ensures that Bioventus maintains its competitive edge through scientifically advanced and cost-efficient treatments. The Chief Technology Officer & Vice President, Research Development Pain & Restorative Therapies collaborates closely with commercial teams to translate technological advancements into market-ready products, driving clinical effectiveness and patient outcomes. McBride's expertise is fundamental to Bioventus's commitment to active healing innovation.
Helen Leupold - Senior Vice President, Chief Human Resources Officer
Helen Leupold, the Senior Vice President, Chief Human Resources Officer at Bioventus, leads the company's human capital strategy and organizational development. Leupold is responsible for cultivating a high-performance culture that supports Bioventus's mission of active healing innovation. This involves attracting, developing, and retaining top talent across all global functions, ensuring the workforce is equipped to drive the creation and delivery of clinically effective, cost-efficient medical treatments. Helen Leupold oversees all human resources operations, including talent management, compensation and benefits, and employee relations, fostering an environment conducive to innovation and collaboration. The Senior Vice President, Chief Human Resources Officer ensures that Bioventus's people strategies directly support the company's strategic objectives and its commitment to enhancing the body's natural healing processes. Leupold's leadership is vital in building a cohesive and motivated team dedicated to Bioventus's success.
Explore Leadership Teams in Manufacturing
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership
TM
PF
TS
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership
CS
CV
TM
CAIRE, headquartered in Ball Ground, Georgia, is a manufacturer of oxygen supply equipment. They specialize in stationary and portable oxygen concentrators.
Company Leadership MM
RA
FH
PA
Ultradent Products, headquartered in South Jordan, Utah, is a company that specializes in the manufacturing and supply of dental equipment.
Company Leadership DA
MV
JD
TL
Frequently Asked Questions Regarding Bioventus Top Executives and Leadership Team
